- Implantable VNS Devices
- External VNS Devices
Vagus Nerve Stimulation (VNS) Devices Market size was valued at USD 562.8 million in 2022 and is expected to reach USD 1,198.2 million by 2028, at a significant CAGR of 11.4% from 2023-2029. Vagus nerve stimulation process involves implantation of a device that stimulates the vagus nerve with electrical impulse. The vagus nerves are a pair of nerves that start in the brain and run through the body. These nerves play a major role in receiving messages between the brain and the body. The vagus nerve stimulation is most often used to treat epilepsy when other treatments havent worked. Vagus nerve stimulation devices are designed to prevent seizures by sending regular, mild pulses of electrical energy to the brain via the vagus nerve. Vagus nerve stimulation device is sometimes referred to as a cardiac pacemaker for the brain. The device is placed under the skin on the chest wall and a wire runs from it to the vagus nerve in the neck. The vagus nerve travels through neck and passes between the chest and abdomen and the lower part of the brain. Vagus nerve stimulation (VNS) is a medical treatment that involves delivering electrical impulses to the vagus nerve in order to manage and treat various illnesses such as depression and epilepsy. The stimulator is implanted under the skin on the chest, where the wire connects it to the left vagal nerve, in this procedure.
Vagus Nerve Stimulation (VNS) Devices Market Key Devolpments:
- In October 2019, LivaNova PLC (NASDAQ:LIVN) (LivaNova or the Company), a market-leading medical technology company, received U.S. Food and Drug Administration (FDA) approvals for its latest Vagus Nerve Stimulation Therapy (VNS Therapy) System, which consists of the SenTiv implantable generator and the next-generation VNS Therapy Programming System for the treatment of patients with drug-resistant epilepsy.
Vagus Nerve Stimulation (VNS) Devices Market Summary
Study Period
2024-2030
Base Year
2023
CAGR
11.4%
Largest Market
Asia-Pacific
Fastest Growing Market
North-America
Vagus Nerve Stimulation (VNS) Devices Market Dynamics
According to the WHO, neurological disorders are responsible for 4.5%-11% of all illnesses. The Increasing prevalence of neurological disorders such as migraine and epilepsy among all age groups is expected to drive the market revenue growth. The increasing R&D activities, favorable reimbursement policies are expected to fuel the growth of the Vagus Nerve Stimulation (VNS) devices market. However, the higher treatment costs may hinder the growth of the market. According to the Epilepsy Foundation, VNS therapy currently costs approximately USD 30,000.
North-America Got Significant Share
Vagus Nerve Stimulation (VNS) Devices Market Regional Analysis
Geographically, global vagus nerve stimulation (VNS) devices market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America Vagus nerve stimulation (VNS) devices market is the fastest growing region. The increasing prevalence of the neurological disorders and the rise in the adoption of the VNS devices for the treatment of various neurological disorders expected to add fuel the market revenue growth. European market stands next to the North America market. Asia Pacific is the region expected to offer lucrative opportunities owing to rapid development in healthcare technology with a huge patient pool.
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The vagus nerve stimulation (VNS) devices market report provides granular level information about the market size, regional market share, historic market (2018-2022) and forecast (2023-2029)
- The report covers in-detail insights about the competitors overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments and startups details that are actively working in the market
- The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
- The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porters Five Force Analysis in addition to recent technology advancements and innovations in the market
Vagus Nerve Stimulation (VNS) Devices Market Segmentation
By Product Type
By Application
- Depression
- Epilepsy
- Migraine
By End User
- Hospitals
- Ambulatory Surgical Centers (ASCs)
- Others
By Geography
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East Africa
Frequently Asked Questions
The key segments covered in the Vagus Nerve Stimulation (VNS) Devices Market are technology, components, application, and end-users.
The Vagus Nerve Stimulation (VNS) Devices Market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
The Vagus Nerve Stimulation (VNS) Devices Market key players LivaNova PLC (UK), EnteroMedics Inc. (US), ElectroCore Medical LLC (US), Boston Scientific Corporation (US), Cyberonics, Inc. (US), NeuroMetrix, Inc. (US), ImThera Medical (US), Inspire Medical Systems, Inc. (US)
| 1.Executive Summary |
| 2.Global Vagus Nerve Stimulation (VNS) Devices Market Introduction |
| 2.1.Global Vagus Nerve Stimulation (VNS) Devices Market - Taxonomy |
| 2.2.Global Vagus Nerve Stimulation (VNS) Devices Market - Definitions |
| 2.2.1.Product Type |
| 2.2.2.Application |
| 2.2.3.End user |
| 2.2.4.Region |
| 3.Global Vagus Nerve Stimulation (VNS) Devices Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Vagus Nerve Stimulation (VNS) Devices Market Analysis, 2018 - 2022 and Forecast 2023 - 2029 |
| 4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Vagus Nerve Stimulation (VNS) Devices Market By Product Type, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 5.1. Implantable VNS Devices |
| 5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. External VNS Devices |
| 5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 6.Global Vagus Nerve Stimulation (VNS) Devices Market By Application, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 6.1. Depression |
| 6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Epilepsy |
| 6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Migraine |
| 6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 7.Global Vagus Nerve Stimulation (VNS) Devices Market By End user, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 7.1. Hospitals |
| 7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Ambulatory Surgical Centers (ASCs) |
| 7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Others |
| 7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 8.Global Vagus Nerve Stimulation (VNS) Devices Market By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia Pacific (APAC) |
| 8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Middle East and Africa (MEA) |
| 8.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Latin America |
| 8.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9.North America Vagus Nerve Stimulation (VNS) Devices Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 9.1. Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Implantable VNS Devices |
| 9.1.2.External VNS Devices |
| 9.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Depression |
| 9.2.2.Epilepsy |
| 9.2.3.Migraine |
| 9.3. End user Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Hospitals |
| 9.3.2.Ambulatory Surgical Centers (ASCs) |
| 9.3.3.Others |
| 9.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.4.1.United States of America (USA) |
| 9.4.2.Canada |
| 10.Europe Vagus Nerve Stimulation (VNS) Devices Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 10.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Implantable VNS Devices |
| 10.1.2.External VNS Devices |
| 10.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Depression |
| 10.2.2.Epilepsy |
| 10.2.3.Migraine |
| 10.3. End user Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Hospitals |
| 10.3.2.Ambulatory Surgical Centers (ASCs) |
| 10.3.3.Others |
| 10.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Germany |
| 10.4.2.France |
| 10.4.3.Italy |
| 10.4.4.United Kingdom (UK) |
| 10.4.5.Spain |
| 10.4.6.Rest of EU |
| 11.Asia Pacific (APAC) Vagus Nerve Stimulation (VNS) Devices Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 11.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Implantable VNS Devices |
| 11.1.2.External VNS Devices |
| 11.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Depression |
| 11.2.2.Epilepsy |
| 11.2.3.Migraine |
| 11.3. End user Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Hospitals |
| 11.3.2.Ambulatory Surgical Centers (ASCs) |
| 11.3.3.Others |
| 11.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.China |
| 11.4.2.India |
| 11.4.3.Australia and New Zealand (ANZ) |
| 11.4.4.Japan |
| 11.4.5.Rest of APAC |
| 12.Middle East and Africa (MEA) Vagus Nerve Stimulation (VNS) Devices Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 12.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Implantable VNS Devices |
| 12.1.2.External VNS Devices |
| 12.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Depression |
| 12.2.2.Epilepsy |
| 12.2.3.Migraine |
| 12.3. End user Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Hospitals |
| 12.3.2.Ambulatory Surgical Centers (ASCs) |
| 12.3.3.Others |
| 12.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.GCC Countries |
| 12.4.2.South Africa |
| 12.4.3.Rest of MEA |
| 13.Latin America Vagus Nerve Stimulation (VNS) Devices Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 13.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Implantable VNS Devices |
| 13.1.2.External VNS Devices |
| 13.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Depression |
| 13.2.2.Epilepsy |
| 13.2.3.Migraine |
| 13.3. End user Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Hospitals |
| 13.3.2.Ambulatory Surgical Centers (ASCs) |
| 13.3.3.Others |
| 13.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Brazil |
| 13.4.2.Mexico |
| 13.4.3.Rest of LA |
| 14. Competition Landscape |
| 14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 14.2.1.LivaNova PLC (UK) |
| 14.2.2.EnteroMedics Inc. (US) |
| 14.2.3.ElectroCore Medical LLC (US) |
| 14.2.4.Boston Scientific Corporation (US) |
| 14.2.5.Cyberonics, Inc. (US) |
| 14.2.6.NeuroMetrix, Inc.(US) |
| 14.2.7.ImThera Medical (US) |
| 14.2.8.Inspire Medical Systems, Inc.(US) |
| 15. Research Methodology |
| 16. Appendix and Abbreviations |
- LivaNova PLC (UK)
- EnteroMedics Inc. (US)
- ElectroCore Medical LLC (US)
- Boston Scientific Corporation (US)
- Cyberonics, Inc. (US)
- NeuroMetrix, Inc.(US)
- ImThera Medical (US)
- Inspire Medical Systems, Inc.(US)